Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 2
1954 1
1955 1
1957 1
1958 5
1959 2
1960 3
1961 1
1962 2
1963 1
1965 1
1967 3
1968 2
1969 4
1970 2
1971 3
1972 2
1973 3
1975 3
1976 3
1977 4
1978 5
1979 10
1980 7
1981 12
1982 10
1983 11
1984 12
1985 17
1986 8
1987 15
1988 13
1989 16
1990 15
1991 18
1992 24
1993 17
1994 26
1995 20
1996 27
1997 25
1998 34
1999 35
2000 38
2001 22
2002 33
2003 26
2004 42
2005 30
2006 48
2007 55
2008 67
2009 82
2010 69
2011 95
2012 102
2013 110
2014 105
2015 113
2016 120
2017 110
2018 124
2019 121
2020 150
2021 179
2022 132
2023 138
2024 58
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

2,344 results

Results by year

Filters applied: . Clear all
Page 1
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD. Turner D, et al. Among authors: rubin d. Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19. Gastroenterology. 2021. PMID: 33359090
ESPEN guideline on hospital nutrition.
Thibault R, Abbasoglu O, Ioannou E, Meija L, Ottens-Oussoren K, Pichard C, Rothenberg E, Rubin D, Siljamäki-Ojansuu U, Vaillant MF, Bischoff SC. Thibault R, et al. Among authors: rubin d. Clin Nutr. 2021 Dec;40(12):5684-5709. doi: 10.1016/j.clnu.2021.09.039. Epub 2021 Oct 20. Clin Nutr. 2021. PMID: 34742138 Free article.
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, D'Hoore A, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Kotze PG, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, Picoraro JA, Vermeire S, Sandborn WJ, Silverberg MS, Pardi DS. Shen B, et al. Among authors: rubin dt. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):69-95. doi: 10.1016/S2468-1253(21)00214-4. Epub 2021 Nov 10. Lancet Gastroenterol Hepatol. 2022. PMID: 34774224 Review.
Brachial and lumbosacral plexopathies: A review.
Rubin DI. Rubin DI. Clin Neurophysiol Pract. 2020 Aug 13;5:173-193. doi: 10.1016/j.cnp.2020.07.005. eCollection 2020. Clin Neurophysiol Pract. 2020. PMID: 32954064 Free PMC article. Review.
Treat-to-target and sequencing therapies in Crohn's disease.
Garcia NM, Cohen NA, Rubin DT. Garcia NM, et al. Among authors: rubin dt. United European Gastroenterol J. 2022 Dec;10(10):1121-1128. doi: 10.1002/ueg2.12336. Epub 2022 Dec 12. United European Gastroenterol J. 2022. PMID: 36507876 Free PMC article. Review.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
D'Haens G, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, Ferrante M. D'Haens G, et al. Among authors: rubin dt. Lancet. 2022 May 28;399(10340):2015-2030. doi: 10.1016/S0140-6736(22)00467-6. Lancet. 2022. PMID: 35644154 Clinical Trial.
New targets in inflammatory bowel disease therapy: 2021.
Cohen NA, Rubin DT. Cohen NA, et al. Among authors: rubin dt. Curr Opin Gastroenterol. 2021 Jul 1;37(4):357-363. doi: 10.1097/MOG.0000000000000740. Curr Opin Gastroenterol. 2021. PMID: 34059604 Free PMC article. Review.
Long-term safety of vedolizumab for inflammatory bowel disease.
Loftus EV Jr, Feagan BG, Panaccione R, Colombel JF, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Vermeire S. Loftus EV Jr, et al. Among authors: rubin dt. Aliment Pharmacol Ther. 2020 Oct;52(8):1353-1365. doi: 10.1111/apt.16060. Epub 2020 Sep 2. Aliment Pharmacol Ther. 2020. PMID: 32876349 Free PMC article. Clinical Trial.
2,344 results